Aytu Biopharma, Inc.
AYTU
$2.39
$0.0954.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.99M | 788.00K | 1.47M | -4.62M | -2.89M |
| Total Depreciation and Amortization | 1.32M | 1.34M | 1.43M | 1.94M | 1.53M |
| Total Amortization of Deferred Charges | 27.00K | 28.00K | 27.00K | 597.00K | 161.00K |
| Total Other Non-Cash Items | -1.63M | -2.51M | -3.32M | 1.33M | -783.00K |
| Change in Net Operating Assets | -10.16M | 3.26M | -794.00K | -42.00K | 1.72M |
| Cash from Operations | -6.46M | 2.91M | -1.19M | -788.00K | -254.00K |
| Capital Expenditure | -69.00K | -6.00K | -136.00K | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 151.00K | 517.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -34.00K | -45.00K |
| Cash from Investing | -69.00K | 145.00K | 381.00K | -34.00K | -45.00K |
| Total Debt Issued | 6.02M | -258.00K | 1.88M | 13.81M | 18.00K |
| Total Debt Repaid | -464.00K | -465.00K | -464.00K | -15.65M | 512.00K |
| Issuance of Common Stock | -- | -- | -- | 3.38M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.25M | -2.04M | -500.00K | -475.00K | 0.00 |
| Cash from Financing | 4.30M | -2.76M | 911.00K | 1.07M | 530.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.23M | 290.00K | 102.00K | 246.00K | 231.00K |